U.S. Department of Defense Awards Rafa Laboratories Production FOLLOW-ON Agreement of over $45 million
The Advanced Anticonvulsant System (AAS) - Midazolam autoinjector, delivers enhanced capability to warfighters. This first in market product was developed by Rafa in cooperation with the U.S.
Source: finanznachrichten.de